Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation
作者:Carlos Jaramillo、J. Eugenio de Diego、Chafiq Hamdouchi、Elizabeth Collins、Heather Keyser、Concha Sánchez-Martı́nez、Miriam del Prado、Bryan Norman、Harold B. Brooks、Scott A. Watkins、Charles D. Spencer、Jack Alan Dempsey、Bryan D. Anderson、Robert M. Campbell、Tellie Leggett、Bharvin Patel、Richard M. Schultz、Juan Espinosa、Michal Vieth、Faming Zhang、David E. Timm
DOI:10.1016/j.bmcl.2004.09.053
日期:2004.12
We have identified a novel structuralclass of protein serine/threonine kinase inhibitors comprised of an aminoimidazo[1,2-a]pyridine nucleus. Compounds from this family are shown to potently inhibit cyclin-dependent kinases by competing with ATP for binding to a catalytic subunit of the protein. Structure-based design approach was used to direct this chemical scaffold toward generating potent and